TRDA$4.66-8.81%
Entrada Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$181.44M
Float & O/S:
Inst Own:
DilutionScan read 43 of Entrada Therapeutics, Inc.'s SEC filings and found 1 warrant series, 2 ATM programs and 2 shelf registrations on file for TRDA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.